“…Of the 19 included systematic reviews, 26 % ( n = 5) ( Bolinski et al., 2020 ; Huber et al., 2022 ; Lin et al., 2022 ; Luo, Zhang, Liu, Ma & Jennings, 2022 ; Oliveira Silva et al., 2023 ) studies were rated as “high”, 26 % ( n = 5) ( Gong et al., 2023 ) ( Yang, Guo, Cheng & Zhang, 2022 ) ( Harrer et al., 2019 ; Huntley et al., 2019 ; Ma, Zhang & Cui, 2019 ) as “moderate”, 37 % ( n = 7) ( Chandler et al., 2022 ; Du et al., 2022 ) ( Chen et al., 2021 ; Lo et al., 2018 ; Luan et al., 2022 ) ( Huang, Nigatu, Smail-Crevier, Zhang & Wang, 2018 ; Song, Liu, Huang, Wu & Tao, 2021 ) as “low” and 11 % ( n = 2) ( Regehr, Glancy & Pitts, 2013 ; Zhang, Li & Wang, 2022 ) as “critically low” quality with the AMSTAR2 scoring system. Supplementary Table 1 presented the details of the quality of each included study evaluated using the AMSTAR2 tool.…”